In the first half of a two-part column, Sullivan Smith, MD, Medical Director of the Cookeville (Tennessee) Regional Medical Center, discusses the basics of “bath salts” and “plant food,” and what substance abuse professionals need to know about these popular synthetic drugs.
Addiction is a complex lifelong disease which, if unaddressed, commonly results in death of the patient. Dr. Stuart Gitlow of the American Society of Addiction Medicine asks, shouldn’t we have some research to determine to whom these patients should be referred?
Research has contributed much knowledge over the decades to smarter prevention of addiction, more efficient early interventions, better and more sustained treatment outcomes, and wiser policies. Now it’s time for research to transform all this knowledge into solutions, says A. Thomas McLellan, PhD, CEO of the Treatment Research Institute.
The Treatment Research Institute announced that A. Thomas McLellan, PhD, has returned to continue his leadership role as CEO of the nonprofit organization.
The journal Addiction Science & Clinical Practice is now being published by BioMed Central, the company announced.
Some insurance companies deny coverage for opioid abuse treatment, according to an Oklahoma addiction specialist.
While experimenting with drugs and alcohol was once considered a rite of passage into early adulthood, the average age of onset of alcohol or other substance use of adolescents entering addiction treatment is now below the age of 13, explains Susan Broderick of Georgetown University’s Public Policy Institute.
Treating long-term heroin users with medically prescribed heroin is more cost-effective than methadone, a new study suggests.
Major policy changes are needed to resolve the tension between providing adequate pain relief and tackling the epidemic of prescription opioid overdoses, according to drug policy expert Keith Humphreys, PhD.
A new study suggests teenagers with “pathologic” Internet use are more likely to admit to drug abuse.